Marqibo

Related by string. * * Marqibo TM *

Related by context. All words. (Click for frequent words.) 70 blinatumomab 70 pralatrexate 70 Azedra 69 CoFactor 69 MGCD# [001] 69 picoplatin 69 perifosine 69 Troxatyl 69 obatoclax 69 ADVEXIN 69 EOquin 68 satraplatin 68 Clolar 68 TELINTRA 68 clofarabine 68 TELCYTA 68 registrational 68 carfilzomib 68 belinostat 68 glufosfamide 68 lintuzumab 67 tanespimycin 67 MOZOBIL 67 Alocrest 67 talactoferrin 67 Phase Ib 66 Amrubicin 66 BAY #-# 66 AP# [003] 66 teduglutide 66 mifamurtide 66 Targretin 66 INCB# [001] 66 ruxolitinib 66 rALLy trial 66 ofatumumab 66 ixabepilone 66 Fodosine 66 valopicitabine 66 Icatibant 66 Perifosine 66 ZEVALIN 66 celgosivir 66 vilazodone 65 custirsen 65 Xanafide 65 Mepact 65 EFAPROXYN 65 PXD# 65 ganetespib 65 Onco TCS 65 Dacogen injection 65 Phenoptin 65 relapsed refractory 65 rNAPc2 65 PROMACTA 65 dirucotide 65 HspE7 65 Triolex 65 HuMax CD4 65 elotuzumab 65 XmAb# 65 Neurodex 65 panitumumab 65 NGX# 65 HuLuc# 65 HGS ETR1 65 FOLOTYN 65 IL# PE#QQR 65 oral prodrug 65 liprotamase 65 HGS# 65 maribavir 65 Ceplene 65 dasatinib 65 NDA submission 65 enzastaurin 64 Archexin 64 Ceflatonin 64 Phase Ib study 64 CR# vcMMAE 64 Advexin 64 Xcytrin 64 investigational compound 64 TYZEKA 64 TOCOSOL Paclitaxel 64 Onrigin 64 sapacitabine 64 PREOS 64 Proxinium TM 64 alvespimycin 64 IMGN# 64 rALLy 64 ofatumumab HuMax CD# 64 vosaroxin 64 PEG SN# 64 thymalfasin 64 Cloretazine R VNP#M 64 Annamycin 64 ONCONASE 64 AEG# 64 Corlux 64 Allovectin 7 64 IMC A# 64 ISTODAX 64 Mozobil 64 Zelrix 64 HER2 positive metastatic breast 64 BiovaxID 64 otelixizumab 64 GATTEX 64 Evoltra 64 CD# antibody [001] 64 Vilazodone 64 Panzem 64 Treanda 64 amrubicin 64 tamibarotene 64 Dacogen 64 Acetavance 64 Vidaza 64 ZOLINZA 64 GALNS 64 Panzem R 64 zanolimumab 64 Phase IIb trials 64 FavId 64 MAA submission 64 oral ridaforolimus 64 Onconase 64 Aurexis 64 Velcade bortezomib 64 daclizumab 64 zalutumumab 64 PSN# [002] 64 VEGF Trap 64 Satraplatin 63 IRX 2 63 HuMax EGFr 63 Traficet EN 63 voreloxin 63 AeroLEF TM 63 ISIS # 63 AQ4N 63 ATL# [001] 63 Bezielle 63 anticancer compound 63 cancer immunotherapies 63 bafetinib 63 JAK inhibitor 63 rALLy clinical trial 63 vinorelbine 63 neratinib 63 vidofludimus 63 Marqibo TM 63 T DM1 63 PS# [001] 63 INCB# [002] 63 SinuNase 63 registrational trial 63 Cloretazine ® 63 Phase IIa trial 63 romiplostim 63 Chemophase 63 Amplimexon 63 abiraterone acetate 63 HuMax CD# 63 alvimopan 63 tezampanel 63 relapsed multiple myeloma 63 investigational monoclonal antibody 63 Phase 2a trial 63 T Pred 63 octreotide implant 63 mipomersen 63 Riquent 63 Pixantrone 63 Phase 2b trial 63 DXL# 63 pertuzumab 63 RDEA# 63 Omacetaxine 63 subcutaneous formulation 63 Genasense 63 confirmatory Phase III 63 deforolimus 63 MyVax R 63 OncoVEX GM CSF 63 YONDELIS 63 OMAPRO 63 Phase 2b clinical 63 OncoVEX 63 BLA submission 63 OPAXIO 63 pradefovir 63 azacitidine 63 Biologics License Application BLA 63 follicular NHL 63 torezolid phosphate 62 docetaxel Taxotere R 62 Leukine 62 sNDA 62 Fludara 62 romidepsin 62 UPLYSO 62 phase IIa clinical 62 Nuvion 62 Allovectin 7 R 62 SILENOR TM 62 Omigard 62 PLK1 SNALP 62 axitinib 62 Junovan 62 Asentar 62 Orathecin 62 Panzem R NCD 62 ONTAK 62 L MTP PE 62 Zerenex 62 Evoltra ® 62 Carfilzomib 62 tesmilifene 62 Biologics License Application 62 dacetuzumab 62 mapatumumab 62 paclitaxel Taxol ® 62 tezampanel NGX# 62 Clolar ® 62 BLA filing 62 Jevtana 62 investigational drug 62 phase IIb clinical 62 EndoTAG TM -1 62 Zolinza 62 Tarceva TM 62 Bronchitol 62 OvaRex ® MAb 62 epratuzumab 62 TREANDA 62 sunitinib malate 62 methylnaltrexone 62 L BLP# 62 StaphVAX 62 Telintra 62 ZYBRESTAT 62 ASA# 62 Clofarabine 62 ridaforolimus 62 Urocidin 62 Phase Ib clinical 62 Nasulin 62 Zalbin 62 sNDA filing 62 hematological cancers 62 cetuximab Erbitux ® 62 New Drug Application 62 OncoGel 62 Virulizin R 62 omacetaxine 62 omacetaxine mepesuccinate 62 Plenaxis TM 62 Amigal 62 CHOP chemotherapy 62 FTY# 62 liposomal formulation 62 Imprime PGG 62 Dyloject TM 62 LY# [003] 62 lumiliximab 62 MAXY G# 62 LEP ETU 62 GRN#L 62 ILLUMINATE 62 TRISENOX 62 forodesine 62 Personalized Immunotherapy 62 brentuximab vedotin 62 INC# 62 dextromethorphan quinidine 62 CYT# 62 VELCADE 62 Revimmune 62 Targretin capsules 62 tesetaxel 62 HGS ETR2 62 Evoltra R 62 PEG PAL 62 PDE4 inhibitor 62 non metastatic osteosarcoma 62 Omapro 62 histamine dihydrochloride 62 pivotal Phase III 62 CINTREDEKIN BESUDOTOX 62 Viramidine 62 Phase 1b clinical 61 eltrombopag 61 PREOS R 61 Civacir 61 APF# 61 Plicera 61 Phase #/#a trial 61 pomalidomide 61 Phase III clinical 61 Sym# 61 ponatinib 61 eniluracil 61 ALN PCS 61 Firazyr 61 pediatric acute lymphoblastic 61 FOLOTYN ® 61 Veronate 61 OXi# 61 IMA# 61 TBC# 61 AZILECT R 61 temsirolimus 61 milatuzumab 61 tafamidis 61 Dasatinib 61 ANA# 61 vemurafenib 61 nimotuzumab 61 Tasigna 61 refractory Hodgkin lymphoma 61 lapatinib Tykerb 61 Zenvia ™ 61 Phase III clinical trials 61 oritavancin 61 ceftaroline 61 Fibrillex TM 61 DAVANAT 61 voclosporin 61 generation purine nucleoside 61 Alzhemed TM 61 cetuximab Erbitux R 61 BCX# 61 seliciclib CYC# 61 prGCD 61 forodesine hydrochloride 61 virus HCV protease inhibitor 61 Azixa 61 Numax 61 Nebido 61 Huntexil 61 histone deacetylase HDAC inhibitor 61 sargramostim 61 dalbavancin 61 NEBIDO 61 entinostat 61 Promacta 61 Phase IIb clinical 61 Phase 1b trial 61 lomitapide 61 davunetide 61 SNT MC# 61 Cotara 61 pixantrone 61 atacicept 61 investigational therapies 61 NPSP# 61 RSD# 61 tiapamil 61 KNS # 61 refractory indolent non 61 ELACYT 61 veltuzumab 61 INT# [002] 61 PNP inhibitor 61 ASONEP 61 imatinib Gleevec ® 61 phase IIb 61 Cloretazine R 61 Phase 1b 61 PROVENGE 61 Gencaro 61 R#/MEM # 61 TYKERB 61 CA4P 61 trastuzumab Herceptin 61 AVN# [001] 61 Taxotere ® 61 peginesatide 61 relapsed refractory multiple myeloma 61 Androxal 61 Insegia 61 cutaneous T cell 61 Trastuzumab 61 Tyrima 61 Cloretazine 61 BEXXAR 61 Mipomersen 61 TEMODAL 61 bosutinib 61 YERVOY 61 Pralatrexate 61 NDA resubmission 61 decitabine 61 Quinamed 61 bendamustine 61 investigational humanized monoclonal antibody 61 vorinostat 61 cintredekin besudotox 61 Taxotere R 61 Ventavis 61 Nexavar ® 61 Phase IIIb clinical 61 EOquin TM 61 ALN TTR# 61 CIMZIA TM 61 denufosol 61 refractory multiple myeloma 61 humanized anti 61 AFRESA 61 DAVANAT R 61 Kuvan 61 reslizumab 61 diabetic neuropathic pain 61 REVLIMID 61 Tasigna nilotinib 61 Telcyta 61 refractory chronic lymphocytic 61 pseudobulbar affect PBA 61 TKM ApoB 60 THALOMID 60 GAP #B# 60 Restanza 60 AzaSite Plus 60 hematologic malignancies 60 sBLA 60 imatinib mesylate Gleevec 60 Picoplatin 60 cell lymphoma CTCL 60 SUTENT 60 Phase IIa clinical 60 apaziquone 60 MBP# [001] 60 tramiprosate 60 BiovaxID TM 60 Reolysin 60 Rituxan rituximab 60 nilotinib 60 LHRH antagonist 60 lorvotuzumab mertansine 60 elagolix 60 myelofibrosis 60 favorable pharmacokinetic profile 60 Folotyn 60 incyclinide 60 TRIOLEX 60 fidaxomicin 60 Relivar 60 L Annamycin 60 LibiGel ® 60 huC# DM4 60 PRTX 60 Zensana 60 Zenvia 60 Laquinimod 60 Phenserine 60 Bortezomib 60 ANTEGREN 60 Stedivaze 60 cangrelor 60 MabCampath 60 Zensana TM 60 Zingo TM 60 Anturol 60 CCX# 60 KRN# 60 PRT# 60 Revlimid lenalidomide 60 #D#C# 60 SinuNase TM 60 Apoptone 60 Targeted Chemotherapy 60 ABRAXANE ® 60 ARIKACE 60 #I TM# 60 Alpharadin 60 ISENTRESS 60 Dapagliflozin 60 palifosfamide 60 Phase Ib II 60 BENLYSTA 60 Vasovist 60 Vicinium TM 60 XYOTAX 60 Phase III trials 60 bazedoxifene 60 trastuzumab DM1 T DM1 60 Bicifadine 60 Genasense ® oblimersen 60 Onalta 60 CYC# 60 ALN RSV# 60 biologic therapy 60 Avastin bevacizumab 60 MyVax 60 StemEx 60 faropenem 60 Phase IIa trials 60 LAF# 60 Phase 2b study 60 TAFA# 60 nab paclitaxel 60 ELND# 60 Specifid 60 ATPace TM 60 IND submission 60 Elagolix 60 Tarvacin 60 indibulin 60 ONCASPAR 60 GED aPC 60 zileuton 60 APD# 60 ocrelizumab 60 mRCC 60 ularitide 60 registrational studies 60 autologous cellular immunotherapy 60 Omnitarg 60 Vectibix 60 Rhucin 60 albinterferon alfa 2b 60 alemtuzumab Campath 60 brentuximab vedotin SGN 60 omega interferon 60 Altastaph 60 PANVAC VF 60 Phase 2a 60 epothilone 60 Pixuvri 60 visilizumab 60 Aplidin 60 Celgene Revlimid 60 Herceptin trastuzumab 60 ambrisentan 60 orBec 60 XYOTAX TM 60 telbivudine 60 temozolomide 60 sorafenib Nexavar 60 Virulizin ® 60 investigational 60 phase IIb trial 60 Zarnestra 60 Orphan Drug designations 60 anti leukemic 60 ABRAXANE 60 preclinical studies 60 fenofibric acid 60 AeroLEF 60 IAP inhibitors 60 immunotherapeutic agent 60 investigational compounds 60 MoxDuo IR 60 ZENPEP 60 Serdaxin 60 Symadex 60 Benlysta belimumab 60 application sNDA 59 AMD# [003] 59 Zybrestat 59 hematological malignancies 59 pharmacokinetic 59 balsalazide tablet 59 TRISENOX ® 59 ALN TTR 59 Allovectin 7 ® 59 Removab 59 alefacept 59 Glufosfamide 59 indolent NHL 59 Evoltra TM 59 bortezomib Velcade R 59 ONGLYZA ™ 59 Eltrombopag 59 AEGR 59 nitazoxanide 59 Golimumab 59 Topical Interferon Alpha 2b 59 Biological License Application 59 Raptiva ® 59 azficel T 59 Vidaza R 59 BEMA TM Fentanyl 59 INTELENCE 59 Pivotal Phase III 59 dasatinib Sprycel ® 59 epigenetic therapies 59 Nanobody 59 Glybera 59 pivotal Phase 59 RIGScan CR 59 Vectibix panitumumab 59 regorafenib 59 anidulafungin 59 Soliris TM eculizumab 59 Capesaris 59 MAGE A3 ASCI 59 CORLUX 59 imatinib Gleevec 59 Nexavar sorafenib 59 IIa trial 59 PI3K/Akt pathway inhibitor 59 elacytarabine 59 preclinical 59 mTOR inhibitor 59 Belinostat 59 lesinurad 59 Clevudine 59 Voreloxin 59 bicifadine 59 Tamibarotene 59 CD3 monoclonal antibody 59 Campath 59 Neulasta ® 59 Xinlay 59 OvaRex R 59 velaglucerase alfa 59 rhThrombin 59 DPP4 59 pegloticase 59 Reverset 59 vascular disrupting agent 59 paclitaxel Taxol R 59 AMR# 59 Vandetanib 59 SPRYCEL 59 selective androgen receptor modulator 59 rFIXFc 59 SUPPRELIN R LA 59 Irinotecan 59 DOS# 59 Xcellerated T Cells 59 DR Cysteamine 59 PCK# 59 Phase IIa 59 ataluren 59 PROVENGE sipuleucel T 59 dasatinib Sprycel 59 TACI Ig 59 Phase IIb clinical trials 59 RSR# 59 Octreolin 59 Zavesca R 59 HQK 59 acyclovir Lauriad R 59 Viprinex 59 pegfilgrastim 59 VEGF inhibitor 59 taxane 59 PDX pralatrexate 59 Tavocept 59 Sandostatin LAR 59 Androxal ® 59 BRIM2 59 Leukine ® 59 Complete Response 59 Blinatumomab 59 mertansine 59 CD# monoclonal antibody 59 pharmacokinetic PK 59 refractory PTCL 59 docetaxel chemotherapy 59 nonclinical studies 59 radiation sensitizer 59 SPRYCEL ® 59 gefitinib Iressa 59 FUSILEV 59 Aflibercept 59 chronic lymphocytic leukemia CLL 59 PEP# [003] 59 investigational immunotherapy 59 B CLL 59 Vidaza azacitidine 59 TLK# 59 phase Ib 59 T#I [002] 59 Campath alemtuzumab 59 Phase 2b 59 pitavastatin 59 NP2 Enkephalin 59 Pruvel 59 MAP# 59 Cellegesic 59 Cardio Vascu Grow 59 Phase 2a clinical 59 Aryplase 59 QNEXA 59 AEZS 59 XL# [003] 59 paclitaxel Taxol 59 LEUKINE 59 BrachySil 59 maximally tolerated dose 59 panitumumab Vectibix 59 CCR9 antagonist 59 ONCONASE R 59 Biologic License Application BLA 59 Increlex ® 59 Pazopanib 59 talabostat 59 UVIDEM 59 PEG Interferon lambda 59 bevacizumab Avastin 59 vandetanib 59 ospemifene 59 crizotinib PF # 59 Azedra TM 59 TNFerade 59 VIDAZA 59 Synavive 59 Taxotere docetaxel 59 SparVax TM 59 HCD# [002] 59 bevacizumab Avastin ® 59 Phase IIb trial 59 trabectedin 59 SEBIVO 59 dose escalation Phase 59 VAPRISOL 59 Pirfenidone 59 Ophena TM 59 Arranon 59 Menerba 59 galiximab 59 docetaxel Taxotere 59 lucinactant 59 LibiGel 59 ATL/TV# 59 melphalan prednisone 59 IDX# 59 Erbitux cetuximab 59 HDAC Inhibitor 59 Saforis 59 IMiDs 59 REVLIMID R 59 PhosLo 59 baminercept 59 DPX Survivac 59 Rituximab 59 Pertuzumab 59 receptor tyrosine kinase inhibitor 59 heavily pretreated 59 Surfaxin LS 59 ProLindac 58 chronic myeloid leukemia CML 58 Torisel 58 Strativa 58 PREZISTA r 58 Neuradiab 58 nucleoside analog 58 ADVEXIN p# therapy 58 seliciclib 58 oral formulation 58 Orazol 58 Vaprisol 58 Ceplene TM 58 supplemental biologics 58 Octreotide 58 Telaprevir 58 Luteinizing Hormone Releasing Hormone 58 plus DOXIL 58 cilengitide 58 Mylotarg 58 AMEVIVE 58 MGCD# [002] 58 Luveniq 58 MDS AML 58 Hycamtin 58 remission induction 58 castration resistant prostate cancer 58 NU# [001] 58 TYGACIL 58 relapsed ovarian cancer 58 squalamine 58 Phase IIb 58 ICA # 58 MEK inhibitors 58 orally bioavailable 58 Ostarine 58 Synvisc One 58 Ipilimumab 58 VALSTAR 58 Loramyc R 58 metastatic hormone refractory 58 INVIRASE 58 Diamyd ® 58 DU #b 58 BYDUREON 58 rilonacept 58 SAR# [004] 58 GAMMAGARD 58 MEK inhibitor RDEA# 58 aflibercept 58 Gemzar ® 58 TRV# [001] 58 Cimzia ® certolizumab pegol 58 IgG1 monoclonal antibody 58 KIACTA ™ 58 CLORETAZINE TM VNP#M 58 NVA# 58 Zenvia TM 58 Catena ® 58 AZILECT ® 58 Darusentan 58 Gleevec imatinib mesylate 58 adecatumumab 58 adipiplon 58 Hyphanox 58 Technosphere Insulin 58 refractory gout 58 fluoropyrimidine 58 metastatic renal cell carcinoma 58 BAL# [002] 58 infusional 5-FU/LV 58 IRESSA 58 Xcytrin R 58 OHR/AVR# 58 REOLYSIN ® 58 telaprevir dosed 58 rindopepimut 58 preclinically 58 severe hypercholesterolemia 58 cetuximab Erbitux 58 Pimavanserin 58 RAPAFLO 58 Cimzia TM 58 DPP4 inhibitor 58 metaglidasen 58 Tezampanel 58 LymphoStat B belimumab 58 LE DT 58 Atiprimod 58 BCR ABL inhibitors 58 dimebon 58 HCV protease inhibitor 58 ProSavin 58 PSMA ADC 58 PrevOnco ™ 58 Myocet 58 Anthim 58 Neo Urinary Conduit 58 Exelixis compounds 58 TRANSDUR Sufentanil 58 surrogate endpoint 58 nalbuphine ER 58 orBec R 58 proteasome inhibitor 58 Fampridine SR 58 erlotinib Tarceva ® 58 Æterna Zentaris 58 Onalta ™ 58 MDV# 58 Vidofludimus 58 RGB # 58 HEPLISAV 58 Tarceva erlotinib 58 refractory AML 58 CAPHOSOL 58 DAVANAT ® 58 leukemia AML 58 CEQ# 58 Doxil 58 Combidex 58 Gabapentin GR 58 ostarine 58 MNTX 58 motesanib 58 standard chemotherapy regimen 58 ZEGERID Capsules 58 TG# [003] 58 Tekamlo 58 Gliadel Wafer 58 immunomodulator 58 Menveo 58 docetaxel Taxotere ® 58 ganaxolone 58 PRECISE trial 58 urocortin 2 58 nucleoside 58 Abiraterone acetate 58 Cinryze ™ 58 pharmacokinetic PK profile 58 Contrave 58 Serdaxin ® 58 oral methylnaltrexone 58 Cintredekin Besudotox 58 erlotinib Tarceva 58 MyVax ® 58 oral taxane 58 tivozanib 58 Voraxaze 58 Lucanix R 58 brivaracetam 58 CRx 58 Zorbtive TM 58 FUSILEV ® 58 Sular formulation 58 tolerability 58 pirfenidone 58 unique alkylating agent 58 Ridaforolimus 58 anticancer agent 58 Ketotransdel 58 Ambrisentan 58 AGGRASTAT ® 58 Fx #A 58 CIMZIA ™ 58 Cinryze TM 58 Seliciclib 58 Privigen 58 Rescula 58 lenalidomide Revlimid R 58 Telavancin 58 PRX # 58 SomatoKine 58 Locteron ® 58 PEGPH# 58 Androxal TM 58 tipifarnib 58 targeted antifolate 58 sodium glucose cotransporter 58 NOXAFIL 58 Polymer Microspheres 58 Dalbavancin 58 corticosteroid dexamethasone 58 oral rivaroxaban 58 systemic anaplastic large 58 Locteron 58 mCRC patients 58 lapatinib 58 CBLC# 58 Phase Ia 58 sodium Injection 58 Fludara ® 58 Rebif ® 58 gastrointestinal stromal tumors GIST 58 Q#IR 58 tramiprosate Alzhemed TM 58 RG# [001] 58 Emezine 58 VNP#M 58 Vitaxin 58 Renvela 58 candidate Zenvia 58 IMC #B 58 Oncaspar 58 canakinumab 58 Linjeta TM 58 MEPACT 58 Talabostat 58 ERBITUX 58 systemic ALCL 58 VitiGam 58 dacarbazine 58 HoFH 58 SILENOR 58 Epratuzumab 58 Aclasta 58 IMiD 58 iniparib 58 Loramyc 58 follicular non 58 JAK1 58 oncolytic virus therapies 58 CRMD# 58 Vion Pharmaceuticals 58 relapsed leukemia 58 indiplon capsules 58 alogliptin 58 hormone refractory prostate cancer 58 Intravenous CP 58 European Medicines Evaluation 58 Denufosol 58 CANCIDAS 58 Panitumumab 58 Pradefovir 58 NXL# 58 Theratope 58 inhaled liposomal ciprofloxacin 58 leukemia CLL 58 EndoTAG 58 hA# 58 Chrysalin 58 tubulin inhibitor 58 oxymorphone ER 58 Celator 58 Cethrin 58 LUVENIQ 58 molecular entities NMEs 58 low dose cytarabine 58 CDP# 58 ZEVALIN ® 58 Camptosar ® 58 Sprycel 58 Revlimid

Back to home page